[
  {
    "ts": null,
    "headline": "FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths",
    "summary": "U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths.  The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk.  The agency said some of the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA.",
    "url": "https://finnhub.io/api/news?id=b24ab47ad9e17c7a1334793d222473800f3c51699b81fc4ad52944a99721633c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754513480,
      "headline": "FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths",
      "id": 136246354,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths.  The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk.  The agency said some of the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA.",
      "url": "https://finnhub.io/api/news?id=b24ab47ad9e17c7a1334793d222473800f3c51699b81fc4ad52944a99721633c"
    }
  },
  {
    "ts": null,
    "headline": "ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y",
    "summary": "Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.",
    "url": "https://finnhub.io/api/news?id=421a50caaff0b168784e9aa19e757f839f0e844cebfe1e97652022f012944541",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754500260,
      "headline": "ACB Stock Down as Q1 Earnings Miss Estimates, Revenues Up Y/Y",
      "id": 136240898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Aurora Cannabis stock slips after Q1 earnings miss, but revenue climbs 17.5% year over year on strong global medical cannabis demand.",
      "url": "https://finnhub.io/api/news?id=421a50caaff0b168784e9aa19e757f839f0e844cebfe1e97652022f012944541"
    }
  },
  {
    "ts": null,
    "headline": "Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down",
    "summary": "AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.",
    "url": "https://finnhub.io/api/news?id=9aba2f09835f299e268d703bcb6fff51abf02c1a2d7de44c6aa7e5b43ffdb409",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754500080,
      "headline": "Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down",
      "id": 136240899,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.",
      "url": "https://finnhub.io/api/news?id=9aba2f09835f299e268d703bcb6fff51abf02c1a2d7de44c6aa7e5b43ffdb409"
    }
  },
  {
    "ts": null,
    "headline": "QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand",
    "summary": "QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.",
    "url": "https://finnhub.io/api/news?id=be5bfa3223849dd7bc6562b842ea0f58c21db2be80683a828760b5d98d8c1927",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754499720,
      "headline": "QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand",
      "id": 136240900,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "QDEL stock rises 12.8% after Q2 earnings beat. Adjusted margins improve amid soft revenue and ongoing business headwinds.",
      "url": "https://finnhub.io/api/news?id=be5bfa3223849dd7bc6562b842ea0f58c21db2be80683a828760b5d98d8c1927"
    }
  },
  {
    "ts": null,
    "headline": "DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands",
    "summary": "DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.",
    "url": "https://finnhub.io/api/news?id=4c1bb626469298548c8657cac86c18d63e72c51dcfeb8f60ae68428aaff36743",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498940,
      "headline": "DaVita Stock Down Despite Q2 Earnings Beat, Gross Margin Expands",
      "id": 136240901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "DVA reports strong second-quarter 2025 results with earnings and revenue beat, along with a boost in gross margin, driven by core operations.",
      "url": "https://finnhub.io/api/news?id=4c1bb626469298548c8657cac86c18d63e72c51dcfeb8f60ae68428aaff36743"
    }
  },
  {
    "ts": null,
    "headline": "MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand",
    "summary": "Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=cf0b241549f0ffd0467287e6a63217ad60ee64a57fd046c128d0fea80b6558b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498760,
      "headline": "MASI Stock Slips Despite Q2 Earnings and Revenue Beat, Margins Expand",
      "id": 136240902,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Masimo's second-quarter 2025 performance beats earnings and revenue estimates, expands margins and lifts 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=cf0b241549f0ffd0467287e6a63217ad60ee64a57fd046c128d0fea80b6558b9"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=4ff53f36a1296b97386e1bbc8e71780cf1233aa112601e1d337bfdce3ed89120",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754498100,
      "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
      "id": 136251762,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=4ff53f36a1296b97386e1bbc8e71780cf1233aa112601e1d337bfdce3ed89120"
    }
  },
  {
    "ts": null,
    "headline": "CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View",
    "summary": "Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.",
    "url": "https://finnhub.io/api/news?id=e5e95122889f75128b7f3b717c8927662739b09fedd6402dcc46eeb5a7647450",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754491140,
      "headline": "CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View",
      "id": 136239130,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Clover Health's Q2 revenues rise 34%, but raised Insurance BER guidance and margin pressures cause shares to tumble post-earnings.",
      "url": "https://finnhub.io/api/news?id=e5e95122889f75128b7f3b717c8927662739b09fedd6402dcc46eeb5a7647450"
    }
  },
  {
    "ts": null,
    "headline": "FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y",
    "summary": "Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.",
    "url": "https://finnhub.io/api/news?id=61468710ea41daf820a7cb92926b92d9f54d3f12f232bb3dca9671380ebca051",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754491140,
      "headline": "FMS Stock Rises as Q2 Earnings Beat Estimates, Revenues Gain Y/Y",
      "id": 136239129,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Fresenius Medical stock rises as Q2 earnings and revenues top estimates, driven by solid organic growth and expanding margins.",
      "url": "https://finnhub.io/api/news?id=61468710ea41daf820a7cb92926b92d9f54d3f12f232bb3dca9671380ebca051"
    }
  },
  {
    "ts": null,
    "headline": "COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised",
    "summary": "Cencora posts strong Q3 results with earnings and revenues surpassing estimates; raises FY25 EPS guidance on robust U.S. segment growth.",
    "url": "https://finnhub.io/api/news?id=727c553ca570de12528e547014d2a723f083d2d282cc6a302c9fce03a0024621",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754490480,
      "headline": "COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised",
      "id": 136239131,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Cencora posts strong Q3 results with earnings and revenues surpassing estimates; raises FY25 EPS guidance on robust U.S. segment growth.",
      "url": "https://finnhub.io/api/news?id=727c553ca570de12528e547014d2a723f083d2d282cc6a302c9fce03a0024621"
    }
  },
  {
    "ts": null,
    "headline": "CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View",
    "summary": "Charles River shares jump 9.3% pre-market after Q2 earnings and revenues beat estimates. The company raises its 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=b4409c4a7afb9624671795188dc21c6e238e3f8ed9725be14ba36b65f984f1da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754486640,
      "headline": "CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View",
      "id": 136237333,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Charles River shares jump 9.3% pre-market after Q2 earnings and revenues beat estimates. The company raises its 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=b4409c4a7afb9624671795188dc21c6e238e3f8ed9725be14ba36b65f984f1da"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls",
    "summary": "TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.",
    "url": "https://finnhub.io/api/news?id=6ea212a33991328bd64c42eabeae037655a3c80b707a363582b79171a1491323",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754485500,
      "headline": "Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls",
      "id": 136237334,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TECH tops Q4 EPS estimates and posts solid revenues, but shrinking margins and operating loss drag shares lower.",
      "url": "https://finnhub.io/api/news?id=6ea212a33991328bd64c42eabeae037655a3c80b707a363582b79171a1491323"
    }
  },
  {
    "ts": null,
    "headline": "Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions",
    "summary": "LONDON & BOSTON, August 06, 2025--Keyron appoints former FDA and Boston Scientific leaders as ForePass—a breakthrough device for severe metabolic disease—prepares for clinical trials",
    "url": "https://finnhub.io/api/news?id=694d1423d96638f69677bdb5a239b95963e71f313c1520b7f772a99cfb842829",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754482020,
      "headline": "Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions",
      "id": 136237335,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "LONDON & BOSTON, August 06, 2025--Keyron appoints former FDA and Boston Scientific leaders as ForePass—a breakthrough device for severe metabolic disease—prepares for clinical trials",
      "url": "https://finnhub.io/api/news?id=694d1423d96638f69677bdb5a239b95963e71f313c1520b7f772a99cfb842829"
    }
  },
  {
    "ts": null,
    "headline": "ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors",
    "summary": "Buchanan is former CFO and COO of Silk Road Medical, where he successfully scaled a growth-stage medical device company, leading to an acquisition by Boston Scientific. Buchanan, formerly a venture capitalist with the Vertical Group, is also an active investor, advisor, and board member for several innovative medical device companies and healthcare investment funds. EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading",
    "url": "https://finnhub.io/api/news?id=65e3ffe392a13c6f8d37a62b8e5644ae69b7f93c393211203ece7487c247a50f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754458200,
      "headline": "ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors",
      "id": 136232377,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Buchanan is former CFO and COO of Silk Road Medical, where he successfully scaled a growth-stage medical device company, leading to an acquisition by Boston Scientific. Buchanan, formerly a venture capitalist with the Vertical Group, is also an active investor, advisor, and board member for several innovative medical device companies and healthcare investment funds. EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading",
      "url": "https://finnhub.io/api/news?id=65e3ffe392a13c6f8d37a62b8e5644ae69b7f93c393211203ece7487c247a50f"
    }
  }
]